A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 6 X users

patent: 1 patent

Citations

dimensions_citation: 63 Dimensions

Readers on

mendeley: 64 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 63 publications that cite this research output.

63

The most recent citing publications are shown below. View all 63 publications that cite this research output on Dimensions.

Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study

Article in Annals of Oncology (September 2024)

Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study

Preprint in medRxiv (July 2024)

Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors

Article in Alimentary Pharmacology & Therapeutics (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.